Genedata and Axxam announce high throughput screening data analysis collaboration
Genedata, a provider of in silico solutions for the pharmaceutical and life science industries, and Axxam, a biotechnology research organization offering early-stage discovery research services for the life science industry, have signed a multi-year contract for the implementation of the Genedata Screener® data analysis and management platform into Axxam`s high throughput screening process.
With an increasing number of pharma and life science companies outsourcing entire stages of their research cycle, the contributions of contract research organizations (CROs) to drug development have never been more crucial. Faster development, earlier decisions on project failures, and higher approval success rates are becoming the norm. To continuously meet those high standards, Axxam relies on Genedata Screener. Screener's high-quality, high-performance modular system rapidly and flexibly analyzes, integrates and manages all assay data and then combines it with chemical, pharmacological and in vivo information to support Axxam scientists in prioritizing compounds and identifying quality lead structures with the highest confidence. Screener`s open and scalable architecture integrates with existing infrastructures, which allows it to be tailored to specific discovery processes, maximizing value.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Mystery of colloidal chains solved
Golden Nano-Dumbbells - Selective binding of gold nanoparticles to the ends of rod-shaped viruses
New technique for exploring structural dynamics of nanoworld
Fingerprint breakthrough hope in US double murder probe - Technique developed by University of Leicester and Northamptonshire police
Bruker Acquires Electron Microscopy Company - High-end STEM Technology Expands Bruker’s Portfolio for Materials Science Research
How do we taste sugar, bacon and coffee? - A new chemical pathway that helps the brain detect sweet, savory and bitter flavors
Fritsch as Authorized Economic Operator (AEO-F) certified
Dr. Marc Stricker appointed new Managing Director at LAUDA
Mount Sinai researchers develop database to help accelerate drug discovery